2012 Oct 1 [updated 2015 Jul 27]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.
Vibrio cholerae virulence is blocked by chitosan oligosaccharide-mediated inhibition of ChsR activity.
Liu Y, Wu J, Liu R, Li F, Xuan L, Wang Q, Li D, Chen X, Sun H, Li X, Jin C, Huang D, Li L, Tang G, Liu B.
Nat Microbiol. 2024 Nov;9(11):2909-2922. doi: 10.1038/s41564-024-01823-6. Epub 2024 Oct 16.
PMID:39414933
Genetic susceptibility to cholera.
Levine MM, Nalin DR, Rennels MB, Hornick RB, Sotman S, Van Blerk G, Hughes TP, O'Donnell S, Barua D.
Ann Hum Biol. 1979 Jul-Aug;6(4):369-74. doi: 10.1080/03014467900003751.
PMID:394667
Genomic epidemiology reveals multidrug resistant plasmid spread between Vibrio cholerae lineages in Yemen.
Lassalle F, Al-Shalali S, Al-Hakimi M, Njamkepo E, Bashir IM, Dorman MJ, Rauzier J, Blackwell GA, Taylor-Brown A, Beale MA, Cazares A, Al-Somainy AA, Al-Mahbashi A, Almoayed K, Aldawla M, Al-Harazi A, Quilici ML, Weill FX, Dhabaan G, Thomson NR.
Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
Islam K, Hossain M, Kelly M, Mayo Smith LM, Charles RC, Bhuiyan TR, Kováč P, Xu P, LaRocque RC, Calderwood SB, Simon JK, Chen WH, Haney D, Lock M, Lyon CE, Kirkpatrick BD, Cohen M, Levine MM, Gurwith M, Harris JB, Qadri F, Ryan ET.